|
1
|
Ohtsu A, Boku N, Muro K, Chin K, Muto M,
Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, et al:
Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous
cell carcinoma of the esophagus. J Clin Oncol. 17:2915–2921.
1999.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cooper JS, Guo MD, Herskovic A, Macdonald
JS, Martenson JA Jr, Al-Sarraf M, Byhardt R, Russell AH, Beitler
JJ, Spencer S, et al: Chemoradiotherapy of locally advanced
esophageal cancer: Long-term follow-up of a prospective randomized
trial (RTOG 85-01). Radiation therapy oncology group. JAMA.
281:1623–1627. 1999.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hironaka S, Ohtsu A, Boku N, Muto M,
Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S,
et al: Nonrandomized comparison between definitive
chemoradiotherapy and radical surgery in patients with T(2-3)
N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat
Oncol Biol Phys. 57:425–433. 2003.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Monjazeb AM and Blackstock AW: The impact
of multimodality therapy of distal esophageal and gastroesophageal
junction adenocarcinomas on treatment-related toxicity and
complications. Semin Radiat Oncol. 23:60–73. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lutkenhaus LJ, Kamphuis M, van Wieringen
N, Hulshof MC and Bel A: Reduction in cardiac volume during
chemoradiotherapy for patients with esophageal cancer. Radiother
Oncol. 109:200–203. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Haj Mohammad N, Kamphuis M, Hulshof MC,
Lutkenhaus LJ, Gisbertz SS, Bergman JJ, de Bruin-Bon HA, Geijsen
ED, Bel A, Boekholdt SM, et al: Reduction of heart volume during
neoadjuvant chemoradiation in patients with resectable esophageal
cancer. Radiother Oncol. 114:91–95. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang X, Wang JZ, Li JB, Zhang YJ, Li FX,
Wang W, Guo YL, Shao Q, Xu M, Liu XJ, et al: Changes in cardiac
volume determined with repeated enhanced 4DCT during
chemoradiotherapy for esophageal cancer. Radiat Oncol.
13(181)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nallapareddy S, Wilding GE, Yang G, Iyer R
and Javle M: Chemoradiation is a tolerable therapy for older adults
with esophageal cancer. Anticancer Res. 25:3055–3060.
2005.PubMed/NCBI
|
|
9
|
Crosby TD, Brewster AE, Borley A, Perschky
L, Kehagioglou P, Court J and Maughan TS: Definitive chemoradiation
in patients with inoperable oesophageal carcinoma. Br J Cancer.
90:70–75. 2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hatakenaka M, Yonezawa M, Nonoshita T,
Nakamura K, Yabuuchi H, Shioyama Y, Nagao M, Matsuo Y, Kamitani T,
Higo T, et al: Acute cardiac impairment associated with concurrent
chemoradiotherapy for esophageal cancer: Magnetic resonance
evaluation. Int J Radiat Oncol Biol Phys. 83:e67–73.
2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang P, Hu X, Yue J, Meng X, Han D, Sun
X, Yang G, Wang S, Wang X and Yu J: Early detection of
radiation-induced heart disease using (99m)Tc-MIBI SPECT gated
myocardial perfusion imaging in patients with oesophageal cancer
during radiotherapy. Radiother Oncol. 115:171–178. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Alajaji W, Xu B, Sripariwuth A, Menon V,
Kumar A, Schleicher M, Isma'eel H, Cremer PC, Bolen MA and Klein
AL: Noninvasive multimodality imaging for the diagnosis of
constrictive pericarditis. Circ Cardiovasc Imaging.
11(e007878)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Atkins KM, Chaunzwa TL, Lamba N, Bitterman
DS, Rawal B, Bredfeldt J, Williams CL, Kozono DE, Baldini EH,
Nohria A, et al: Association of left anterior descending coronary
artery radiation dose with major adverse cardiac events and
mortality in patients with non-small cell lung cancer. JAMA Oncol.
7:206–219. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zureick AH, Grzywacz VP, Almahariq MF,
Silverman BR, Vayntraub A, Chen PY, Gustafson GS, Jawad MS and
Dilworth JT: Dose to the left anterior descending artery correlates
with cardiac events after irradiation for breast cancer. Int J
Radiat Oncol Biol Phys. 114:130–139. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang X, Palaskas NL, Hobbs BP, Abe JI,
Nead KT, Yusuf SW, Hermann J, Deswal A and Lin SH: The impact of
radiation dose to heart substructures on major coronary events and
patient survival after chemoradiation therapy for esophageal
cancer. Cancers (Basel). 14(1304)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yegya-Raman N, Ho Lee S, Friedes C, Wang
X, Iocolano M, Kegelman TP, Duan L, Li B, Berlin E, Kim KN, et al:
Cardiac radiation dose is associated with inferior survival but not
cardiac events in patients with locally advanced non-small cell
lung cancer in the era of immune checkpoint inhibitor
consolidation. Radiother Oncol. 190(110005)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Japan Esophageal Society. Japanese
classification of esophageal cancer, 11th edition: part I.
Esophagus. 14:1–36. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Japan Esophageal Society. Japanese
classification of esophageal cancer, 11th edition: part II and III.
Esophagus. 14:37–65. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Duane F, Aznar MC, Bartlett F, Cutter DJ,
Darby SC, Jagsi R, Lorenzen EL, McArdle O, McGale P, Myerson S, et
al: A cardiac contouring atlas for radiotherapy. Radiother Oncol.
122:416–422. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lee J, Hua KL, Hsu SM, Lin JB, Lee CH, Lu
KW, Dai KY, Huang XN, Huang JZ, Wu MH and Chen YJ: Development of
delineation for the left anterior descending coronary artery region
in left breast cancer radiotherapy: An optimized organ at risk.
Radiother Oncol. 122:423–430. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Orso D, Guglielmo N, Federici N, Cugini F,
Ban A, Mearelli F and Copetti R: Accuracy of the caval index and
the expiratory diameter of the inferior vena cava for the diagnosis
of dehydration in elderly. J Ultrasound. 19:203–209.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kies MS, Rosen ST, Tsang TK, Shetty R,
Schneider PA, Wallemark CB and Shields TW: Cisplatin and
5-fluorouracil in the primary management of squamous esophageal
cancer. Cancer. 60:2156–2160. 1987.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kato K, Ito Y, Nozaki I, Daiko H, Kojima
T, Yano M, Ueno M, Nakagawa S, Takagi M, Tsunoda S, et al:
Parallel-group controlled trial of surgery versus chemoradiotherapy
in patients with stage I esophageal squamous cell carcinoma.
Gastroenterology. 161:1878–1886. e2. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ishida K, Ando N, Yamamoto S, Ide H and
Shinoda M: Phase II study of cisplatin and 5-fluorouracil with
concurrent radiotherapy in advanced squamous cell carcinoma of the
esophagus: A japan esophageal oncology group (JEOG)/japan clinical
oncology group trial (JCOG9516). Jpn J Clin Oncol. 34:615–619.
2004.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Umezawa R, Kadoya N, Ota H, Nakajima Y,
Saito M, Takagi H, Takanami K, Takahashi N, Ishikawa Y, Yamamoto T,
et al: Dose-dependent radiation-induced myocardial damage in
esophageal cancer treated with chemoradiotherapy: A prospective
cardiac magnetic resonance imaging study. Adv Radiat Oncol.
5:1170–1178. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sasazuki S, Inoue M, Tsuji I, Sugawara Y,
Tamakoshi A, Matsuo K, Wakai K, Nagata C, Tanaka K, Mizoue T, et
al: Research group for the development and evaluation of cancer
prevention strategies in Japan. Body mass index and mortality from
all causes and major causes in Japanese: Results of a pooled
analysis of 7 large-scale cohort studies. J Epidemiol. 21:417–30.
2011.PubMed/NCBI View Article : Google Scholar
|
